ArticleBMC cardiovascular disorders2025
Diabetic ketoacidosis and hyperosmolar hyperglycemic state in diabetes patients with heart failure: insight from the National inpatient sample.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mapping the storm: a scoping review of diabetic emergencies in Africa.Frontiers in clinical diabetes and healthcare · 2026Review
- Association of cerebrovascular disease with adverse outcomes in patients with diabetic ketoacidosis.Endocrine connections · 2026Article
- Outcomes following hospitalization for diabetic ketoacidosis in patients with cardiovascular disease.Endocrine connections · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS) are acute, life-threatening hyperglycemic conditions in diabetes. We aim to assess in-hospital cardiovascular outcomes of DKA and HHS in type 2 diabetes (T2D) patients with heart failure (HF) and compare both complications.
methodsThe National Inpatient Sample database was used to gather data on T2D patients admitted for HF (primary diagnosis) from 2008 to 2019. The secondary diagnoses were DKA or HHS. The outcomes investigated were mortality, ischemic stroke, acute renal failure, and cardiogenic shock.
resultsDiabetes HF patients with DKA were younger than those without HHS-DKA, more likely to be females, and had a higher prevalence of coronary artery disease and chronic kidney disease. DKA was associated with higher adjusted risk of mortality (aOR = 2.75[2.42-3.13)], ischemic stroke (aOR = 2.51[1.80-3.49]), acute renal failure (aOR = 1.54[1.45-1.64]), and cardiogenic shock (aOR = 2.53[2.19-2.92]. Diabetes HF patients with HHS were also younger but had more comorbidities than those without HHS-DKA. However, HHS was only associated with an increased adjusted risk of acute renal failure (aOR = 1.59[1.49-1.70]. When both hyperglycemic groups were compared, DKA patients were younger and had fewer comorbidities. However, they had a higher adjusted risk of mortality (aOR = 2.90[2.22-3.79] and cardiogenic shock (aOR = 2.86 [2.13-3.83], but not acute renal failure or stroke.
conclusionsDKA and HHS are associated with worse cardiovascular outcomes in heart failure patients with type 2 diabetes. Further, when both conditions were compared, the mortality risk and cardiogenic shock were higher in DKA compared to HHS. Implementing tailored fluid and electrolyte management, optimizing insulin protocols, and enhancing monitoring with early intervention could be lifesaving for these high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.